Post-Translational Modification of MR Activity

Références bibliographiques

• Gomez-Sanchez E, Gomez-Sanchez CE. The multifaceted mineralocorticoid receptor. Comprehensive Physiology. 2014;4(3):965-994
• Jaisser F, Farman N. Emerging roles of the mineralocorticoid receptor in pathology: Toward new paradigms in clinical pharmacology. Pharmacological Reviews. 2016;68(1):49-75
• Shibata S. Context-dependent mechanisms modulating aldosterone signaling in the kidney. Clinical and Experimental Nephrology. 2016;20(5):663-670
• Chapman K, Holmes M, Seckl J. 11beta-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action. Physiological Reviews. 2013;93(3):1139-1206
• Funder JW. Apparent mineralocorticoid excess. The Journal of Steroid Biochemistry and Molecular Biology. 2017;165(Pt A):151-153
• Fuller PJ, Yang J, Young MJ. 30 years of the mineralocorticoid receptor: Coregulators as mediators of mineralocorticoid receptor signaling diversity. The Journal of Endocrinology. 2017;234(1):T23-T34
• Shibata S, Rinehart J, Zhang J, Moeckel G, Castaneda-Bueno M, Stiegler AL, et al. Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia. Cell Metabolism. 2013;18(5):660-671
• Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: Insights into its molecular and (patho)physiological biology. Nuclear Receptor Signaling. 2007;5:e012
• Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: A journey exploring its diversity and specificity of action. Molecular Endocrinology. 2005;19(9):2211-2221
• Lema I, Amazit L, Lamribet K, Fagart J, Blanchard A, Lombes M, et al. RNA-binding protein HuR enhances mineralocorticoid signaling in renal KC3AC1 cells under hypotonicity. Cellular and Molecular Life Sciences. 2017;74(24):4587-4597
• Viengchareun S, Lema I, Lamribet K, Keo V, Blanchard A, Cherradi N, et al. Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control. Journal of the American Society of Nephrology. 2014;25(10):2213-2221
• Butterworth MB, Alvarez de la Rosa D. Regulation of aldosterone Signaling by MicroRNAs. Vitamins and Hormones. 2019;109:69-103. in press
• Mannironi C, Camon J, De Vito F, Biundo A, De Stefano ME, Persiconi I, et al. Acute stress alters amygdala microRNA miR-135a and miR-124 expression: Inferences for corticosteroid dependent stress response. PLoS ONE. 2013;8(9):e73385
• Sober S, Laan M, Annilo T. MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochemical and Biophysical Research Communications. 2010;391(1):727-732
• van Leeuwen N, Caprio M, Blaya C, Fumeron F, Sartorato P, Ronconi V, et al. The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels. Hypertension. 2010;56(5):995-1002
• Galigniana MD, Erlejman AG, Monte M, Gomez-Sanchez C, Piwien-Pilipuk G. The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events. Molecular and Cellular Biology. 2010;30(5):1285-1298
• Grossmann C, Ruhs S, Langenbruch L, Mildenberger S, Stratz N, Schumann K, et al. Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling. Chemistry & Biology. 2012;19(6):742-751
• Hernandez-Diaz I, Giraldez T, Arnau MR, Smits VA, Jaisser F, Farman N, et al. The mineralocorticoid receptor is a constitutive nuclear factor in cardiomyocytes due to hyperactive nuclear localization signals. Endocrinology. 2010;151(8):3888-3899
• Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease. Nature Medicine. 2008;14(12):1370-1376
• Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circulation Research. 2005;96(6):643-650
• Liu W, Wang J, Sauter NK, Pearce D. Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(26):12480-12484
• Nishi M, Tanaka M, Matsuda K, Sunaguchi M, Kawata M. Visualization of glucocorticoid receptor and mineralocorticoid receptor interactions in living cells with GFP-based fluorescence resonance energy transfer. The Journal of Neuroscience. 2004;24(21):4918-4927
• Ruhs S, Nolze A, Hubschmann R, Grossmann C. 30 years of the mineralocorticoid receptor: Nongenomic effects via the mineralocorticoid receptor. The Journal of Endocrinology. 2017;234(1):T107-TT24
• Thomas W, Harvey BJ. Mechanisms underlying rapid aldosterone effects in the kidney. Annual Review of Physiology. 2011;73:335-357
• Faresse N. Post-translational modifications of the mineralocorticoid receptor: How to dress the receptor according to the circumstances? The Journal of Steroid Biochemistry and Molecular Biology. 2014;143:334-342
• Alnemri ES, Maksymowych AB, Robertson NM, Litwack G. Overexpression and characterization of the human mineralocorticoid receptor. The Journal of Biological Chemistry. 1991;266(27):18072-18081
• Galigniana MD. Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases. The Biochemical Journal. 1998;333(Pt 3):555-563
• Le Moellic C, Ouvrard-Pascaud A, Capurro C, Cluzeaud F, Fay M, Jaisser F, et al. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. Journal of the American Society of Nephrology. 2004;15(5):1145-1160
• Hirschberg D, Jagerbrink T, Samskog J, Gustafsson M, Stahlberg M, Alvelius G, et al. Detection of phosphorylated peptides in proteomic analyses using microfluidic compact disk technology. Analytical Chemistry. 2004;76(19):5864-5871
• Faresse N, Debonneville A, Staub O. USP2-45 represses aldosterone mediated responses by decreasing mineralocorticoid receptor availability. Cellular Physiology and Biochemistry. 2013;31(2-3):462-472
• Faresse N, Vitagliano JJ, Staub O. Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation. The FASEB Journal. 2012;26(10):4373-4382
• Tirard M, Almeida OF, Hutzler P, Melchior F, Michaelidis TM. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor. Molecular and Cellular Endocrinology. 2007;268(1-2):20-29
• Yokota K, Shibata H, Kobayashi S, Suda N, Murai A, Kurihara I, et al. Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone. Endocrine Research. 2004;30(4):611-616
• Tallec LP, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A, et al. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: Implication of small ubiquitin-related modifier 1 modification. Molecular Endocrinology. 2003;17(12):2529-2542
• Yokota K, Shibata H, Kurihara I, Kobayashi S, Suda N, Murai-Takeda A, et al. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. The Journal of Biological Chemistry. 2007;282(3):1998-2010
• Lee HA, Lee DY, Cho HM, Kim SY, Iwasaki Y, Kim IK. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circulation Research. 2013;112(7):1004-1012
• Galigniana MD. Stability study on renal type I mineralocorticoid receptor. Life Sciences. 1996;59(7):511-521
• Burgdorf S, Leister P, Scheidtmann KH. TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. The Journal of Biological Chemistry. 2004;279(17):17524-17534
• Ismaili N, Blind R, Garabedian MJ. Stabilization of the unliganded glucocorticoid receptor by TSG101. The Journal of Biological Chemistry. 2005;280(12):11120-11126
• La Rosa P, Pesiri V, Marino M, Acconcia F. 17beta-Estradiol-induced cell proliferation requires estrogen receptor (ER) alpha monoubiquitination. Cellular Signalling. 2011;23(7):1128-1135
• Faresse N, Ruffieux-Daidie D, Salamin M, Gomez-Sanchez CE, Staub O. Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP. American Journal of Physiology. Renal Physiology. 2010;299(6):F1462-F1472
• Nagarajan S, Vohra T, Loffing J, Faresse N. Protein phosphatase 1alpha enhances renal aldosterone signaling via mineralocorticoid receptor stabilization. Molecular and Cellular Endocrinology. 2017;450:74-82
• Amazit L, Le Billan F, Kolkhof P, Lamribet K, Viengchareun S, Fay MR, et al. Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1. The Journal of Biological Chemistry. 2015;290(36):21876-21889
• Fakitsas P, Adam G, Daidie D, van Bemmelen MX, Fouladkou F, Patrignani A, et al. Early aldosterone-induced gene product regulates the epithelial sodium channel by deubiquitylation. Journal of the American Society of Nephrology. 2007;18(4):1084-1092
• Pouly D, Debonneville A, Ruffieux-Daidie D, Maillard M, Abriel H, Loffing J, et al. Mice carrying ubiquitin-specific protease 2 (Usp2) gene inactivation maintain normal sodium balance and blood pressure. American Journal of Physiology. Renal Physiology. 2013;305(1):F21-F30
• Ruhs S, Stratz N, Quarch K, Masch A, Schutkowski M, Gekle M, et al. Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 2. Scientific Reports. 2017;7(1):15340
• Jimenez-Canino R, Lorenzo-Diaz F, Jaisser F, Farman N, Giraldez T, Alvarez de la Rosa D. Histone deacetylase 6-controlled Hsp90 acetylation significantly alters mineralocorticoid receptor subcellular dynamics but not its transcriptional activity. Endocrinology. 2016;157(6):2515-2532
• Scroggins BT, Robzyk K, Wang D, Marcu MG, Tsutsumi S, Beebe K, et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Molecular Cell. 2007;25(1):151-159
• Caamano CA, Morano MI, Patel PD, Watson SJ, Akil H. A bacterially expressed mineralocorticoid receptor is associated in vitro with the 90-kilodalton heat shock protein and shows typical hormone- and DNA-binding characteristics. Biochemistry. 1993;32(33):8589-8595
• Nemoto T, Ohara-Nemoto Y, Sato N, Ota M. Dual roles of 90-kDa heat shock protein in the function of the mineralocorticoid receptor. Journal of Biochemistry. 1993;113(6):769-775
• Hellal-Levy C, Fagart J, Souque A, Rafestin-Oblin ME. Mechanistic aspects of mineralocorticoid receptor activation. Kidney International. 2000;57(4):1250-1255
• Shibata S, Ishizawa K, Wang Q , Xu N, Fujita T, Uchida S, et al. ULK1 phosphorylates and regulates mineralocorticoid receptor. Cell Reports. 2018;24(3):569-576
• Jimenez-Canino R, Fernandes MX, Alvarez de la Rosa D. Phosphorylation of mineralocorticoid receptor ligand binding domain impairs receptor activation and has a dominant negative effect over non-phosphorylated receptors. The Journal of Biological Chemistry. 2016;291(36):19068-19078
• Souque A, Fagart J, Couette B, Rafestin-Oblin ME. Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor. The Journal of Steroid Biochemistry and Molecular Biology. 1996;57(5-6):315-321
• Lupo B, Mesnier D, Auzou G. Cysteines 849 and 942 of human mineralocorticoid receptor are crucial for steroid binding. Biochemistry. 1998;37(35):12153-12159
• Piwien-Pilipuk G, Galigniana MD. Oxidative stress induced by L-buthionine-(S,R)-sulfoximine, a selective inhibitor of glutathione metabolism, abrogates mouse kidney mineralocorticoid receptor function. Biochimica et Biophysica Acta. 2000;1495(3):263-280
• Piwien-Pilipuk G, Ayala A, Machado A, Galigniana MD. Impairment of mineralocorticoid receptor (MR)-dependent biological response by oxidative stress and aging: Correlation with post-translational modification of MR and decreased ADP-ribosylatable level of elongating factor 2 in kidney cells. The Journal of Biological Chemistry. 2002;277(14):11896-11903
• Jimenez-Canino R, Lorenzo-Diaz F, Odermatt A, Bailey MA, Livingstone DEW, Jaisser F, et al. 11beta-HSD2 SUMOylation modulates cortisol-induced mineralocorticoid receptor nuclear translocation independently of effects on transactivation. Endocrinology. 2017;158(11):4047-4063
• Fejes-Toth G, Pearce D, Naray-Fejes-Toth A. Subcellular localization of mineralocorticoid receptors in living cells: Effects of receptor agonists and antagonists. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(6):2973-2978
• Ackermann D, Gresko N, Carrel M, Loffing-Cueni D, Habermehl D, Gomez-Sanchez C, et al. In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: Differential effect of corticosteroids along the distal tubule. American Journal of Physiology. Renal Physiology. 2010;299(6):F1473-F1485
• Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT, et al. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology. 2006;147(3):1343-1348
• Han F, Ozawa H, Matsuda K, Nishi M, Kawata M. Colocalization of mineralocorticoid receptor and glucocorticoid receptor in the hippocampus and hypothalamus. Neuroscience Research. 2005;51(4):371-381
• Echeverria PC, Picard D. Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility. Biochimica et Biophysica Acta. 2010;1803(6):641-649
• Walther RF, Atlas E, Carrigan A, Rouleau Y, Edgecombe A, Visentin L, et al. A serine/threonine-rich motif is one of three nuclear localization signals that determine unidirectional transport of the mineralocorticoid receptor to the nucleus. The Journal of Biological Chemistry. 2005;280(17):17549-17561
• Piwien-Pilipuk G, Galigniana MD. Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor. Molecular and Cellular Endocrinology. 1998;144(1-2):119-130
• Yasuoka S, Kai H, Kajimoto H, Kudo H, Takayama N, Anegawa T, et al. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats. Circulation Journal. 2013;77(6):1474-1481
• Wang RA, Mazumdar A, Vadlamudi RK, Kumar R. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. The EMBO Journal. 2002;21(20):5437-5447
• Marissal-Arvy N, Lombes M, Petterson J, Moisan MP, Mormede P. Gain of function mutation in the mineralocorticoid receptor of the Brown Norway rat. The Journal of Biological Chemistry. 2004;279(38):39232-39239
• Kino T, Jaffe H, Amin ND, Chakrabarti M, Zheng YL, Chrousos GP, et al. Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Molecular Endocrinology. 2010;24(5):941-952
• Borquez DA, Olmos C, Alvarez S, Di Genova A, Maass A, Gonzalez-Billault C. Bioinformatic survey for new physiological substrates of cyclin-dependent kinase 5. Genomics. 2013;101(4):221-228
• Davel AP, Anwar IJ, Jaffe IZ. The endothelial mineralocorticoid receptor: Mediator of the switch from vascular health to disease. Current Opinion in Nephrology and Hypertension. 2017;26(2):97-104
• Yang J, Young MJ. The mineralocorticoid receptor and its coregulators. Journal of Molecular Endocrinology. 2009;43(2):53-64
• Seo M, Song M, Seok YM, Kang SH, Lee HA, Sohn UD, et al. Lysine acetyltransferases cyclic adenosine monophosphate response element-binding binding protein and acetyltransferase p300 attenuate transcriptional activity of the mineralocorticoid receptor through its acetylation. Clinical and Experimental Pharmacology & Physiology. 2015;42(5):559-566
• Gross M, Yang R, Top I, Gasper C, Shuai K. PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene. 2004;23(17):3059-3066
• Martin-Martinez M, Perez-Gordillo FL, Alvarez de la Rosa D, Rodriguez Y, Gerona-Navarro G, Gonzalez-Muniz R, et al. Modulating mineralocorticoid receptor with non-steroidal antagonists. New opportunities for the development of potent and selective ligands without off-target side effects. Journal of Medicinal Chemistry. 2017;60(7):2629-2650
• Su MG, Weng JT, Hsu JB, Huang KY, Chi YH, Lee TY. Investigation and identification of functional post-translational modification sites associated with drug binding and protein-protein interactions. BMC Systems Biology. 2017;11(Suppl 7):132